Literature DB >> 133776

Sialoproteinaemia: lack of correlation with inhibition of in vitro lymphoblastosis induced by phytohaemagglutinin or alloantigen.

B N Gray, R R Kopito, L L Anderson, O L Baralt, C K Connery, E Watkins.   

Abstract

Elevation of serum-bound sialic acid concentration in different disease states fails to correlate significantly with suppressive serum actions in mixed allogeneic lymphocyte cultures or phyto-haemagglutinin cultures. Heat-decomplemented serum from patients with abnormal levels of bound sialic acid was added to parallel cultures containing similar blood lymphocyte populations derived from normal humans. Wide fluctuations of the rate of incorporation of tritiated thymidine into nucleoprotein indicated presence of suppressive elements other than sialoprotein in the added serum components. Serum with rising sialyl concentration derived from patients with cancer showed slight tendency to augment mixed lymphocyte and phytohaemagglutinin responses. The findings suggest that the previously documented nonspecific suppressive action of serum sialoprotein on human host lymphoblastic response to neuraminidase-treated cancer cells represents a mechanism unique to that culture system rather than a manifestation of a general immunoregulatory function of serum sialoprotein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133776      PMCID: PMC1541366     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.

Authors:  R B Nimberg; A H Glasgow; J O Menzoian; M B Constantian; S R Cooperband; J A Mannick; K Schmid
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

2.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

3.  SIALIC ACID AS A MEASURE OF SERUM MUCOPROTEINS.

Authors:  C MCNEIL; C R BERRETT; L Y SU; E F TRENTELMAN; W M HELMICK
Journal:  Am J Clin Pathol       Date:  1965-02       Impact factor: 2.493

4.  Sialic acids in blood serum.

Authors:  E MARTENSSON; A RAAL; L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1958-10

5.  Determination of serum glycoproteins.

Authors:  R J WINZLER
Journal:  Methods Biochem Anal       Date:  1955

6.  Effects of tumor growth on serum glycoprotein concentration in the rat.

Authors:  H E WEIMER; F A QUINN; J REDLICHMOSHIN; H NISHIHARA
Journal:  J Natl Cancer Inst       Date:  1957-09       Impact factor: 13.506

7.  Immunologic approach to cancer therapy.

Authors:  B N Gray; E Watkins
Journal:  Med Clin North Am       Date:  1975-03       Impact factor: 5.456

8.  Photometric determination of sialic acids in serum and cerebrospinal fluid with the thiobarbituric acid method.

Authors:  A SAIFER; S GERSTENFELD
Journal:  Clin Chim Acta       Date:  1962-07       Impact factor: 3.786

9.  An increase of serum alpha-globulin in tumor-bearing hosts and its immunological significance.

Authors:  K Ashikawa; K Inoue; T Shimizu; Y Ishibashi
Journal:  Jpn J Exp Med       Date:  1971-08

10.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

View more
  1 in total

1.  Serum sialic acid and CEA concentrations in human breast cancer.

Authors:  A Hogan-Ryan; J J Fennelly; M Jones; B Cantwell; M J Duffy
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.